Trial Profile
Efficacy of abatacept or tocilizumab in patients with rheumatoid arthritis treated in routine care in Denmark
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 08 Dec 2015 New trial record